Healthcare provider profile · identity verified

Mohammad N Mazid, MD

Family Practice · NORTH BABYLON, NY · NPI 1316064454

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	666	210
Amlodipine Besylate	Amlodipine Besylate	441	137
Metoprolol Succinate	Metoprolol Succinate	413	125
Rosuvastatin Calcium	Rosuvastatin Calcium	284	87
Losartan Potassium	Losartan Potassium	276	90
Gabapentin	Gabapentin	270	94
Simvastatin	Simvastatin	252	73
Metformin Hcl	Metformin Hcl	236	76
Pantoprazole Sodium	Pantoprazole Sodium	223	62
Levothyroxine Sodium	Levothyroxine Sodium	222	63
Allopurinol	Allopurinol	202	54
Metformin Hcl Er	Metformin Hcl	195	65
Tamsulosin Hcl	Tamsulosin Hcl	193	68
Omeprazole	Omeprazole	176	53
Jardiance	Empagliflozin	168	36
Furosemide	Furosemide	161	55
Lisinopril	Lisinopril	155	46
Famotidine	Famotidine	145	54
Eliquis	Apixaban	143	42
Fluticasone Propionate	Fluticasone Propionate	140	68
Montelukast Sodium	Montelukast Sodium	135	40
Enalapril Maleate	Enalapril Maleate	131	35
Calcitriol	Calcitriol	129	46
Warfarin Sodium	Warfarin Sodium	129	15
Trazodone Hcl	Trazodone Hcl	124	23
Escitalopram Oxalate	Escitalopram Oxalate	123	34
Clopidogrel	Clopidogrel Bisulfate	106	33
Albuterol Sulfate Hfa	Albuterol Sulfate	104	33
Metoprolol Tartrate	Metoprolol Tartrate	103	33
Ozempic	Semaglutide	102	23
Hydralazine Hcl	Hydralazine Hcl	100	41
Alendronate Sodium	Alendronate Sodium	93	31
Duloxetine Hcl	Duloxetine Hcl	91	21
Hydrochlorothiazide	Hydrochlorothiazide	90	34
Atenolol	Atenolol	79	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	27
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	75	30
Pravastatin Sodium	Pravastatin Sodium	75	25
Carvedilol	Carvedilol	74	26
Potassium Chloride	Potassium Chloride	71	24
Tramadol Hcl	Tramadol Hcl	70	22
Azelastine Hcl	Azelastine Hcl	65	27
Breo Ellipta	Fluticasone/Vilanterol	65	14
Synthroid	Levothyroxine Sodium	62	20
Farxiga	Dapagliflozin Propanediol	58	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	56	17
Triamcinolone Acetonide	Triamcinolone Acetonide	56	30
Glipizide Er	Glipizide	55	18
Finasteride	Finasteride	54	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	20
Trulicity	Dulaglutide	53	suppressed
Valsartan	Valsartan	52	17
Methylprednisolone	Methylprednisolone	51	36
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Mirtazapine	Mirtazapine	48	14
Mounjaro	Tirzepatide	47	12
Clonazepam	Clonazepam	44	12
Ezetimibe	Ezetimibe	44	17
Spironolactone	Spironolactone	44	14
Oxybutynin Chloride Er	Oxybutynin Chloride	43	17
Irbesartan	Irbesartan	42	15
Januvia	Sitagliptin Phosphate	41	14
Sertraline Hcl	Sertraline Hcl	41	12
Torsemide	Torsemide	41	11
Pregabalin	Pregabalin	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	12
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	38	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	38	suppressed
Naproxen	Naproxen	38	17
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	37	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Glimepiride	Glimepiride	34	13
Ibandronate Sodium	Ibandronate Sodium	34	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	15
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Azithromycin	Azithromycin	32	27
Baclofen	Baclofen	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Donepezil Hcl	Donepezil Hcl	31	12
Tresiba Flextouch U-200	Insulin Degludec	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	12
Fenofibric Acid	Fenofibric Acid (Choline)	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Linzess	Linaclotide	26	suppressed
Topiramate	Topiramate	26	suppressed
Celecoxib	Celecoxib	24	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Ammonium Lactate	Ammonium Lactate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Nystatin	Nystatin	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	16
Fenofibrate	Fenofibrate	22	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	14
Prednisone	Prednisone	22	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	15
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Mupirocin	Mupirocin	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	12
Benazepril Hcl	Benazepril Hcl	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	17
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	17	14
Risedronate Sodium	Risedronate Sodium	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Niacin Er	Niacin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Prolia	Denosumab	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Cefaclor	Cefaclor	12	suppressed
Indapamide	Indapamide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error